Market Research Logo

Global Biologics Market: Size, Trends & Forecast (2018-2022)

Global Biologics Market: Size, Trends & Forecast (2018-2022)

Scope of the Report

The report entitled “Global Biologics Market: Size, Trends & Forecast (2018-2022)”, provides an in-depth analysis of the global biologics market with description of market sizing and growth. The analysis includes market by value, by segment and by region. It also provides a detailed analysis of biologics market in terms of manufacturing process, product-category and therapeutic areas as well.

The report includes a brief regional analysis of North America, Europe and China with their actual and forecasted market size. North America has the largest stake in the global biologics market over the years and is expected to maintain its position in the upcoming years also. Among the Asia countries, China is the largest market and has the potential to grow steadily over the forecasted period.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Abbvie Inc., Samsung Electronics (Samsung Biologics), F. Hoffmann La Roche and Amgen Inc. are some of the key players operating in the global biologics market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are provided.

Company Coverage

Abbvie Inc.
Samsung Electronics (Samsung Biologics)
F. Hoffmann La Roche
Amgen Inc.

Regional Coverage

North America
Europe
China

Executive Summary

Pharmaceutical industry is engaged in the discovery, manufacturing and marketing of pharmaceutical drugs such as legal drugs, vaccines, biologics and a large number of medical devices such as infusion pump, pacemakers, prosthetics, implantable defibrillators etc. Pharmaceutical drugs and devices are subjected to various laws and regulations governing their patent, safety, and efficacy. On an elementary level pharmaceutical drugs are broadly classified into two categories: small molecules (non-biologics) and large molecules (biologics).

Large molecules are mostly made of cells or other living organisms and are used to produce therapeutic proteins or biological molecules. Drugs made up of large molecules are popularly known as biotech drugs, biologics or biopharmaceuticals. The major biologics blockbusters currently available in the market are Humira, Remicade, Enbrel, Avastin and Herceptin.

The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2018-2022, particularly due to increasing biologics approval and growing incidence of chronic conditions among the aging population. The global biologics market is supported by various growth drivers such as increased availability of advanced diagnostics, raising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases, advancement in healthcare & biotechnology, etc. Yet the market faces some challenges which are obstructing the growth of the market. Some of the major challenges faced by the industry are: high cost of biologics, lack of oral absorption, complex regulatory approval etc.


1. Executive Summary
2. Introduction
2.1 Pharmaceutical Industry: An Overview
Table 1: History of Pharmaceutical Industry
2.1.1 Segmentation of Pharmaceutical Industry (Drugs)
Table 2: Pharmaceutical Industry Segments
2.2 Biologics: An Overview
2.2.1 Biologics Definition
2.2.2 Biologics Medical Use
2.2.3 Difference between Chemical Drugs and Biologics
Table 3: Chemical Drugs vs. Biologics
2.2.4 Key Biologics Product US/EU Expiry Date
Table 4: Key Biologics Product US/EU Expiry Date
2.3 Biologics Manufacturing Process
2.3.1 Biologics Manufacturing Process
Table 5: Biologics Manufacturing Process
2.4 Biologics Product-Category
2.4.1 Biologics Product-Category
Table 6: Biologics Product-Category
3. Global Market Analysis
3.1 Global Pharmaceuticals Market Analysis
3.1.1 Global Pharmaceuticals Market by Value
Table 7: Global Pharmaceuticals Market by Value; 2012-2017 (US$ Billion)
Table 8: Global Pharmaceuticals Market by Value; 2018-2022E (US$ Billion)
3.1.2 Global Pharmaceuticals Market by Segments
Table 9: Global Pharmaceuticals Market by Segments; 2017
3.2 Global Biologics Market Analysis
3.2.1 Global Biologics Market by Value
Table 10: Global Biologics Market by Value; 2012-2017 (US$ Billion)
Table 11: Global Biologics Market by Value; 2018-2022E (US$ Billion)
3.2.2 Global Biologics Manufacturing Market by Value
Table 12: Global Biologics Manufacturing Market by Value; 2013-2017
(US$ Billion)
Table 13: Global Biologics Manufacturing Market by Value; 2018-2022E
(US$ Billion)
3.2.3 Global Biologics Market by Product-Category
Table 14: Global Biologics Market by Product-Category; 2017
3.2.4 Global Biologics Market by Therapeutic Areas
Table 15: Global Biologics Market by Therapeutic Areas; 2017
3.2.5 Global Biologics Market by Region
Table 16: Global Biologics Market by Region; 2017
3.2.6 Global Biologics Market Growth Outlook by Region
Table 17: Global Biologics Market Growth Outlook (CAGR) by Region; 2016-2021 (%)
3.2.7 Global Biologics Manufacturing Market by Segments
Table 18: Global Biologics Manufacturing Market by Segments; 2017
3.3 Global Biologics Manufacturing Market: Segment Analysis
3.3.1 Global Bio CMO Market by Value
Table 19: Global Bio CMO Market by Value; 2012-2017 (US$ Billion)
Table 20: Global Bio CMO Market by Value; 2018-2022E (US$ Billion)
3.3.2 Global Biologics In-House Market by Value
Table 21: Global Biologics In-House Market by Value; 2015-2017 (US$ Billion)
Table 22: Global Biologics In-House Market by Value; 2018-2022E (US$ Billion)
3.4 Global Biologics Market: Product Analysis
3.4.1 Global Biologics Monoclonal Antibodies Market by Value
Table 23: Global Biologics Monoclonal Antibodies Market by Value; 2015-2017 (US$ Billion)
Table 24: Global Biologics Monoclonal Antibodies Market by Value; 2018-2022E (US$ Billion)
3.4.2 Global Biologics Recombinant Protein Market by Value
Table 25: Global Biologics Recombinant Protein Market by Value; 2015-2017
(US$ Billion)
Table 26: Global Biologics Recombinant Protein Market by Value; 2018-2022E (US$ Billion)
3.4.3 Global Biologics Vaccines Market by Value
Table 27: Global Biologics Vaccines Market by Value; 2015-2017 (US$ Billion)
Table 28: Global Biologics Vaccines Market by Value; 2018-2022E (US$ Billion)
3.4.4 Global Biologics Regenerative Medicines Market by Value
Table 29: Global Biologics Regenerative Medicine Market by Value; 2015-2017 (US$ Billion)
Table 30: Global Biologics Regenerative Medicine Market by Value; 2018-2022E (US$ Billion)
3.5 Global Biologics Market: Therapeutic Areas Analysis
3.5.1 Global Biologics Inflammatory Market by Value
Table 31: Global Biologics Inflammatory Market by Value; 2015-2017 (US$ Billion)
Table 32: Global Biologics Inflammatory Market by Value; 2018-2022E
(US$ Billion)
3.5.2 Global Biologics Oncology and Immunomodulatory Market by Value
Table 33: Global Biologics Oncology and Immunomodulatory Market by Value; 2015-2017 (US$ Billion)
Table 34: Global Biologics Oncology and Immunomodulatory Market by Value; 2018-2022E (US$ Billion)
3.5.3 Global Biologics Endocrine Market by Value
Table 35: Global Biologics Endocrine Market by Value; 2015-2017 (US$ Billion)
Table 36: Global Biologics Endocrine Market by Value; 2018-2022E (US$ Billion)
3.5.4 Global Biologics Anti-Infectives Market by Value
Table 37: Global Biologics Anti-Infectives Market by Value; 2015-2017
(US$ Billion)
Table 38: Global Biologics Anti-Infectives Market by Value; 2018-2022E
(US$ Billion)
4. Regional Analysis
4.1 North America Biologics Market Analysis
4.1.1 North America Biologics Market by Value
Table 39: North America Biologics Market by Value; 2016-2017 (US$ Billion)
Table 40: North America Biologics Market by Value; 2018-2022E (US$ Billion)
4.2 Europe Biologics Market Analysis
4.2.1 Europe Biologics Market by Value
Table 41: Europe Biologics Market by Value; 2016-2017 (US$ Billion)
Table 42: Europe Biologics Market by Value; 2018-2022E (US$ Billion)
4.3 China Biologics Market Analysis
4.3.1 China Biologics Market by Value
Table 43: China Biologics Market by Value; 2012-2017 (US$ Billion)
Table 44: China Biologics Market by Value; 2018-2022E (US$ Billion)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Biologics Approvals
Table 45: FDA Approved Medicines in US; 2010-2016
5.1.2 Raising Autoimmune Disease Prevalence
Table 46: Prevalence of Diagnosed Autoimmune Conditions; 2016
5.1.3 Growing Number of Biosimilars
Table 47: Major Biologics Patent Expiration between 2015-2025E
5.1.4 Preference of Biologics over Small Molecules
Table 48: Global Biopharmaceuticals (Drugs) Market by Segments; 2006-2020
5.2 Challenges
5.2.1 High Cost
5.2.2 Lack of Oral Absorption
5.2.3 Operational and Technological Challenges
5.2.4 Complex Regulatory Approval
5.3 Market Trends
5.3.1 Increasing Focus on New Therapeutic Areas
Table 49: Current Pharmaceutical Research & Development Pipeline Trends; 2016
5.3.2 Potential Biologics Blockbusters
Table 50: Global Blockbuster Biologics Pipeline; 2017
5.3.3 Advancement in Healthcare and Biotechnology
5.3.4 Commercial Success of Biotech Products
5.3.5 Reimbursement Policy
6. Competitive Landscape
6.1 Global Biologics Market by Players/Drugs
Table 51: Global Biologics Market by Players/Drugs; 2016
7. Company Profiles
7.1 Abbvie Inc.
7.1.1 Business Overview
Table 52: HUMIRA Principal Markets
7.1.2 Financial Overview
Table 53: Abbvie Inc. and Humira Sales; 2102-2016 (US$ Billion)
Table 54: Abbvie Inc. Sales by Geography; 2016
Table 55: Abbvie Inc. Sales by Products; 2016
7.1.3 Business Strategy
7.2 Samsung Electronics (Samsung Biologics)
7.2.1 Business Overview
Table 56: Samsung Electronics Segments Overview
Table 57: Samsung Electronics Ownership Structure
7.2.2 Financial Overview
Table 58: Samsung Electronics and Biologics Revenue; 2012-2016 (US$ Billion)
Table 59: Samsung Electronics Revenue by Segments; 2016
7.2.3 Business Strategy
7.3 F. Hoffmann La Roche
7.3.1 Business Overview
7.3.2 Financial Overview
Table 60: F. Hoffmann-La Roche Sales; 2015-2017 (US$ Billion)
Table 61: F. Hoffmann-La Roche Sales by Segments; 2017
7.3.3 Business Strategy
7.4 Amgen Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
Table 62: Amgen Inc. and ENBREL Sales; 2012-2016 (US$ Billion)
Table 63: Amgen Inc. Sales by Products; 2016
Table 64: ENBREL Sales by Geography; 2016
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report